Pre-eclampsia
- PMID: 15733721
- DOI: 10.1016/S0140-6736(05)17987-2
Pre-eclampsia
Abstract
Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of angiogenic growth factors and increased placental debris in the maternal circulation resulting in a (mainly hypertensive) maternal inflammatory response. The final phenotype, maternal pre-eclamptic syndrome, is further modulated by pre-existing maternal cardiovascular or metabolic fitness. Currently, women at risk are identified on the basis of epidemiological and clinical risk factors, but the diagnostic criteria of pre-eclampsia remain unclear, with no known biomarkers. Treatment is still prenatal care, timely diagnosis, proper management, and timely delivery. Many interventions to lengthen pregnancy (eg, treatment for mild hypertension, plasma-volume expansion, and corticosteroid use) have a poor evidence base. We review findings on the diagnosis, risk factors, and pathogenesis of pre-eclampsia and the present status of its prediction, prevention, and management.
Similar articles
-
Pre-eclampsia.Lancet. 2010 Aug 21;376(9741):631-44. doi: 10.1016/S0140-6736(10)60279-6. Epub 2010 Jul 2. Lancet. 2010. PMID: 20598363 Review.
-
Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.Arch Gynecol Obstet. 2005 Nov;273(1):43-9. doi: 10.1007/s00404-005-0741-3. Epub 2005 Apr 15. Arch Gynecol Obstet. 2005. PMID: 15834580
-
Immunology and genetic of preeclampsia.Clin Dev Immunol. 2006 Jun-Dec;13(2-4):197-201. doi: 10.1080/17402520600876903. Clin Dev Immunol. 2006. PMID: 17162362 Free PMC article. Review.
-
Maternal mortality from preeclampsia/eclampsia.Semin Perinatol. 2012 Feb;36(1):56-9. doi: 10.1053/j.semperi.2011.09.011. Semin Perinatol. 2012. PMID: 22280867
-
Diagnosis, prevention, and management of eclampsia.Obstet Gynecol. 2005 Feb;105(2):402-10. doi: 10.1097/01.AOG.0000152351.13671.99. Obstet Gynecol. 2005. PMID: 15684172 Review.
Cited by
-
Risk of fetal death with preeclampsia.Obstet Gynecol. 2015 Mar;125(3):628-635. doi: 10.1097/AOG.0000000000000696. Obstet Gynecol. 2015. PMID: 25730226 Free PMC article.
-
Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.Am J Physiol Heart Circ Physiol. 2020 Sep 1;319(3):H661-H681. doi: 10.1152/ajpheart.00202.2020. Epub 2020 Aug 7. Am J Physiol Heart Circ Physiol. 2020. PMID: 32762557 Free PMC article. Review.
-
Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases.PLoS One. 2012;7(9):e44572. doi: 10.1371/journal.pone.0044572. Epub 2012 Sep 4. PLoS One. 2012. PMID: 22962618 Free PMC article.
-
Role of corin and atrial natriuretic peptide in preeclampsia.Placenta. 2013 Feb;34(2):89-94. doi: 10.1016/j.placenta.2012.11.016. Epub 2012 Dec 2. Placenta. 2013. PMID: 23211473 Free PMC article. Review.
-
Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.Am J Transl Res. 2016 May 15;8(5):1920-34. eCollection 2016. Am J Transl Res. 2016. PMID: 27347303 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources